Assembly Biosciences (ASMB) Capital Expenditures Growth (5y) (2016 - 2026)
Assembly Biosciences (ASMB) Capital Expenditures Growth (5y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-63.85% |
| Jun 30, 2024 |
-22.78% |
| Mar 31, 2024 |
-60.67% |
| Dec 31, 2023 |
-19.57% |
| Sep 30, 2023 |
29.74% |
| Jun 30, 2023 |
-1.96% |
| Sep 30, 2022 |
-27.32% |
| Dec 31, 2021 |
-30.61% |
| Mar 31, 2021 |
327.21% |
| Jun 30, 2020 |
87.92% |
| Mar 31, 2020 |
16.18% |
| Dec 31, 2019 |
-35.02% |
| Mar 31, 2019 |
256.36% |
| Dec 31, 2018 |
176.27% |
| Jun 30, 2018 |
59.30% |
| Dec 31, 2017 |
1,193.34% |
| Mar 31, 2016 |
-28.97% |
